Recombinant VEGF (Bevacizumab Biosimilar) anticorps

N° du produit ABIN7487763

L’anticorps Souris Chimeric anti-VEGF (Bevacizumab Biosimilar) a été validé pour FACS, ELISA, BR, IP et WB. Il convient pour détecter VEGF (Bevacizumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant VEGF (Bevacizumab Biosimilar) anticorps (ABIN7487763)

Antigène: VEGF (Bevacizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Chimeric

Conjugué: Cet anticorp VEGF (Bevacizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Blocking Reagent (BR), Immunoprecipitation (IP), Western Blotting (WB)

Détail du produit anti-VEGF (Bevacizumab Biosimilar) anticorps

Fonction: Anti-VEGF [Bevacizumab], Mouse IgG2a, kappa

Specificité: This antibody binds native and reduced human VEGF (isoform 165).

Attributs du produit:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Immunogène: Recombinant human VEGF.

Isotype: IgG2a kappa

Information d'application

Indications d'application: This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

Commentaires:

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur VEGF (Bevacizumab Biosimilar)

Antigène: VEGF (Bevacizumab Biosimilar)

Sujet: Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF

UniProt: P15692